Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
Bezuclastinib + sunitinib combination therapy reached median progression free survival (mPFS) of 19.4-months and 33% ORR in subset of advanced GI...
NEW HAVEN, Conn., May 23, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN) today announced that two abstracts, including one for ARV-766 in ...
HOUSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize...
Lifileucel TIL Cell Therapy in Combination with Pembrolizumab DemonstratesDeep, Durable Responses in Frontline Advanced Melanoma Patientsin IOV-CO...
Abstract released today highlights safety, pharmacodynamic and clinical response data with additional data to be presented in a poster session on ...
SANTA CLARA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- NVIDIA will present at the following event for the financial community: BofA Securities Gl...
Poster highlights durable disease stabilization lasting beyond treatment completion Results suggest a unique, multimodal mechanism of action that...
NEWTON, Kan., May 23, 2024 (GLOBE NEWSWIRE) -- Park Aerospace Corp. (NYSE - PKE) announced that it plans to release its financial results for it...
Deckers Outdoor Corp (NYSE:DECK) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the highlights from t...
SHELTON, Conn., May 23, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE:ACU) today announced that it has acquired the assets of Elite Fir...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
34.68%Change Percent:
Omnicell Inc. Company Name:
OMCL Stock Symbol:
NASDAQ Market:
omnicell.com Website: